1. Anti-IgLON5 disease: a novel topic beyond neuroimmunology
- Author
-
Yi-Zong Heng Zhang, You Ni, Yi-Ning Gao, Ding-Ding Shen, Lu He, Dou Yin, Huan-Yu Meng, Qin-Ming Zhou, Ji Hu, and Sheng Chen
- Subjects
anti-iglon5 disease ,autoimmune encephalitis ,human leukocyte antigen ,igg4-related diseases ,iglon5 antibody ,iglons ,immunotherapy ,inflammation ,neurodegeneration ,neuroimmunology ,tauopathy ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Anti-IgLON5 disease is a recently defined autoimmune disorder of the nervous system associated with autoantibodies against IgLON5. Given its broad clinical spectrum and extremely complex pathogenesis, as well as difficulties in its early diagnosis and treatment, anti-IgLON5 disease has become the subject of considerable research attention in the field of neuroimmunology. Anti-IgLON5 disease has characteristics of both autoimmunity and neurodegeneration due to the unique activity of the anti-IgLON5 antibody. Neuropathologic examination revealed the presence of a tauopathy preferentially affecting the hypothalamus and brainstem tegmentum, potentially broadening our understanding of tauopathies. In contrast to that seen with other autoimmune encephalitis-related antibodies, basic studies have demonstrated that IgLON5 antibody-induced neuronal damage and degeneration are irreversible, indicative of a potential link between autoimmunity and neurodegeneration in anti-IgLON5 disease. Herein, we comprehensively review and discuss basic and clinical studies relating to anti-IgLON5 disease to better understand this complicated disorder.
- Published
- 2023
- Full Text
- View/download PDF